Skip to main content
Top
Published in: Clinical Rheumatology 3/2018

01-03-2018 | Review Article

Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study

Authors: Francesco Caso, Antonio Del Puente, Francesca Oliviero, Rosario Peluso, Nicolò Girolimetto, Paolo Bottiglieri, Francesca Foglia, Carolina Benigno, Marco Tasso, Leonardo Punzi, Raffaele Scarpa, Luisa Costa

Published in: Clinical Rheumatology | Issue 3/2018

Login to get access

Abstract

The aim of this study was to evaluate the prevalence of MetS and its components and the level of serum uric acid in patients with PsA and in those with PsA sine psoriasis. A secondary aim of the study was to investigate on correlations of MetS in all study population. Consecutive PsA patients underwent assessment of disease activity and metabolic parameters. Blood samples were collected after 12 h of overnight fasting and analyzed for glucose, lipid profile, serum uric acid, and acute-phase reactants. The NCEP-ACT III criteria were used to identify subjects with MetS. Forty-two patients (52.5%) were classified as having PsA with clinically evident psoriasis (group 1) and 38 (47.5%) as having PsA sine psoriasis (group 2). Group 1, when compared to group 2, showed a significant increase for the frequency of MetS (p = 0.006) and for mean values of diastolic blood pressure (p = 0.0116) and of serum uric acid (p = 0.04). We then aimed at defining determinants of MetS in the entire study population. In the multivariate analysis, three variables reached statistical significance: presence of psoriasis (OR 0.14; p = 0.01), increase of one unit of BMI (OR 1.26; p = 0.001), and smoking habit (OR 5.93; p = 0.02). In our study, the occurrence of MetS and mean levels of serum uric acid were higher in PsA patients with clinical evident psoriasis compared to sine psoriasis PsA. The results also show the potential role of BMI, psoriasis, and smoking as important determinants in the development of MetS in PsA patients.
Literature
4.
go back to reference Lapadula G, Marchesoni A, Salaffi F, Ramonda R, Salvarani C, Punzi L, Costa L, Caso F, Simone D, Baiocchi G, Scioscia C, Di Carlo M, Scarpa R, Ferraccioli G (2016) Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA). Reumatismo 68(3):126–136. https://doi.org/10.4081/reumatismo.2016.913 CrossRefPubMed Lapadula G, Marchesoni A, Salaffi F, Ramonda R, Salvarani C, Punzi L, Costa L, Caso F, Simone D, Baiocchi G, Scioscia C, Di Carlo M, Scarpa R, Ferraccioli G (2016) Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA). Reumatismo 68(3):126–136. https://​doi.​org/​10.​4081/​reumatismo.​2016.​913 CrossRefPubMed
5.
go back to reference Nordmann A, Weber M (1999) Psoriatic arthritis without psoriasis. Schweiz Rundsch Med Prax 4:242–245 Nordmann A, Weber M (1999) Psoriatic arthritis without psoriasis. Schweiz Rundsch Med Prax 4:242–245
7.
go back to reference Scarpa R, Cosentini E, Manguso F, Oriente A, Peluso R, Atteno M, Ayala F, D'Arienzo A, Oriente P (2003) Clinical and genetic aspects of psoriatic arthritis “sine psoriasis”. J Rheumatol 30(12):2638–2640PubMed Scarpa R, Cosentini E, Manguso F, Oriente A, Peluso R, Atteno M, Ayala F, D'Arienzo A, Oriente P (2003) Clinical and genetic aspects of psoriatic arthritis “sine psoriasis”. J Rheumatol 30(12):2638–2640PubMed
8.
go back to reference Taylor W, Gladman D, Helliwell P, CASPAR Study Group et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673CrossRefPubMed Taylor W, Gladman D, Helliwell P, CASPAR Study Group et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673CrossRefPubMed
14.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef
19.
go back to reference Özkan SG, Yazısız H, Behlül A, Gökbelen YA, Borlu F, Yazısız V (2017) Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with psoriatic arthritis. Eur J Rheumatol 4:40–45CrossRefPubMedPubMedCentral Özkan SG, Yazısız H, Behlül A, Gökbelen YA, Borlu F, Yazısız V (2017) Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with psoriatic arthritis. Eur J Rheumatol 4:40–45CrossRefPubMedPubMedCentral
22.
go back to reference Desideri G, Castaldo G, Lombardi A, Mussap M, Testa A, Pontremoli R, Punzi L, Borghi C (2014) Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci 18(9):1295–1306PubMed Desideri G, Castaldo G, Lombardi A, Mussap M, Testa A, Pontremoli R, Punzi L, Borghi C (2014) Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci 18(9):1295–1306PubMed
26.
go back to reference Labitigan M, Bahče-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, Putterman C, Broder A (2014) Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) 66(4):600–607. https://doi.org/10.1002/acr.22185 CrossRef Labitigan M, Bahče-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, Putterman C, Broder A (2014) Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) 66(4):600–607. https://​doi.​org/​10.​1002/​acr.​22185 CrossRef
40.
go back to reference Cook S, Hugli O, Egli M, Vollenweider P, Burcelin R, Nicod P, Thorens B, Scherrer U (2003) Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 133(25-26):360–363PubMed Cook S, Hugli O, Egli M, Vollenweider P, Burcelin R, Nicod P, Thorens B, Scherrer U (2003) Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 133(25-26):360–363PubMed
45.
go back to reference Costa L, Caso F, Atteno M, Del Puente A, Darda MA, Caso P, Ortolan A, Fiocco U, Ramonda R, Punzi L, Scarpa R (2014) Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients. Clin Rheumatol 33(6):833–839. https://doi.org/10.1007/s10067-013-2369-1 PubMed Costa L, Caso F, Atteno M, Del Puente A, Darda MA, Caso P, Ortolan A, Fiocco U, Ramonda R, Punzi L, Scarpa R (2014) Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients. Clin Rheumatol 33(6):833–839. https://​doi.​org/​10.​1007/​s10067-013-2369-1 PubMed
46.
go back to reference Costa L, Caso F, Ramonda R, Del Puente A, Cantarini L, Darda MA, Caso P, Lorenzin M, Fiocco U, Punzi L, Scarpa R (2015) Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study. Immunol Res 61(1-2):147–153. https://doi.org/10.1007/s12026-014-8595-z CrossRefPubMed Costa L, Caso F, Ramonda R, Del Puente A, Cantarini L, Darda MA, Caso P, Lorenzin M, Fiocco U, Punzi L, Scarpa R (2015) Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study. Immunol Res 61(1-2):147–153. https://​doi.​org/​10.​1007/​s12026-014-8595-z CrossRefPubMed
Metadata
Title
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study
Authors
Francesco Caso
Antonio Del Puente
Francesca Oliviero
Rosario Peluso
Nicolò Girolimetto
Paolo Bottiglieri
Francesca Foglia
Carolina Benigno
Marco Tasso
Leonardo Punzi
Raffaele Scarpa
Luisa Costa
Publication date
01-03-2018
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 3/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3975-0

Other articles of this Issue 3/2018

Clinical Rheumatology 3/2018 Go to the issue